Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011-2020.

Stedman, Michael; Taylor, Peter; Premawardhana, Lakdasa; Okosieme, Onyebuchi; Dayan, Colin; Heald, Adrian H

Stedman, Michael; Taylor, Peter; Premawardhana, Lakdasa; Okosieme, Onyebuchi; Dayan, Colin; Heald, Adrian H.

Afiliação

Stedman M; Res Consortium, Andover, UK.
Taylor P; Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UK.
Premawardhana L; Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UK.
Okosieme O; Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UK.
Dayan C; Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UK.
Heald AH; The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.

Clin Endocrinol (Oxf) ; 94(6): 980-989, 2021 06.

Article em En | MEDLINE | ID: mdl-33411974

Assuntos

Hipotireoidismo; Tiroxina; Inglaterra; Humanos; Hipotireoidismo/tratamento farmacológico; Padrões de Prática Médica; Tiroxina/uso terapêutico; Tri-Iodotironina; País de Gales

Palavras-chave

T3; T4; comparison; levothyroxine; liothyronine; prescribing; trends

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Assunto principal: Tiroxina / Hipotireoidismo Tipo de estudo: Health_economic_evaluation Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Clin Endocrinol (Oxf) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google